fincash logo SOLUTIONS

Fincash » Search » Ipca Laboratories Ltd

Ipca Laboratories Ltd

Updated on October 15, 2020

Stock/Share Code - IPCALAB

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)

Below is the details of IPCALAB Ipca Laboratories Ltd

Market Cap₹23,850 Cr.
Current Price ₹2,075.75 as on 21 Oct 20
52 Week High / Low Price₹2,175 / ₹844.2
Face Value₹2
Stock P/E24.49
Book Value₹291.05
Dividend Yield0.27 %
ROCE20.48 %
ROE18.86 %
Sales Growth (3yrs)11.82 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has delivered good profit growth of 20.57% CAGR over last 5 years
Cons: The company has delivered a poor growth of 7.03% over past five years. Tax rate seems low

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma ₹806.2 15.87 ₹47,396.57 Cr. 0.37 ₹780.58 Cr. 20.99 8.82 5924.78 18.73
5. Biocon ₹439.6 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹426.35 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Ipca Labs. ₹141 24.49 ₹23,850.22 Cr. 0.27 ₹453.64 Cr. 243.54 46.91 1485.25 20.48

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ipca Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -8658607828549989488341,0111,2131,1391,0051,485
YOY Sales Growth %-2.23%14.58%16.84%19.70%15.40%10.24%6.69%18.39%21.52%20.21%20.51%46.91%
Expenses -715698673740825716659816951874812897
Material Cost %34.12%34.19%32.75%32.52%31.40%31.63%32.26%35.86%33.78%33.49%32.54%27.43%
Employee Cost %21.65%21.21%21.57%22.88%20.42%18.60%21.21%20.33%18.12%19.11%22.68%16.29%
Operating Profit149162109114173232175195262265193588
OPM %17%19%14%13%17%24%21%19%22%23%19%40%
Other Income111113141413151914181312
Profit before tax1101237278141197141168227233157552
Tax %12%14%28%16%15%19%23%21%14%16%19%18%
Net Profit961065166120160109132196197128454
EPS in Rs7.648.374.075.199.4812.688.6710.4515.5115.5610.1135.90

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -1,2671,5481,8812,3292,7783,2353,0882,8043,1023,1933,6064,3384,842
Sales Growth %21.16%22.19%21.49%23.83%19.28%16.43%-4.54%-9.20%10.65%2.94%12.91%20.31%
Expenses -1,1021,2391,4581,8652,2182,4992,5562,5282,6682,7482,9103,4203,534
Material Cost %41.21%43.25%40.80%38.95%39.27%34.85%37.02%37.33%35.70%34.84%32.16%34.13%
Manufacturing Cost %7.23%6.30%6.63%7.35%10.45%7.94%9.53%9.83%9.24%9.40%9.54%9.11%
Employee Cost %14.54%13.98%13.91%13.83%13.55%14.77%17.53%21.52%21.76%22.32%20.86%20.07%
Other Cost %23.95%16.52%16.19%19.93%16.55%19.68%18.71%21.47%19.29%19.51%18.13%15.52%
Operating Profit1663094234645617365312764354456969181,308
OPM %13%20%22%20%20%23%17%10%14%14%19%21%27%
Other Income2441-212192133282140556557
Profit before tax1142723343694616293581112582835577851,169
Tax %20%23%23%24%28%24%28%17%27%18%18%17%
Net Profit9120925528033147725693188233455652974
EPS in Rs6.933.2519.7921.7425.6037.8320.297.3314.9218.4736.0051.6477.08
Dividend Payout %30%17%16%14%15%13%5%0%7%5%8%10%

Compounded Sales Growth

  • 10 Years:: 10.85%
  • 5 Years:: 7.03%
  • 3 Years:: 11.82%
  • TTM:: 27.74%

Compounded Profit Growth

  • 10 Years:: 12.00%
  • 5 Years:: 20.57%
  • 3 Years:: 51.24%
  • TTM:: 86.80%

Return on Equity

  • 10 Years:: 20.70%
  • 5 Years:: 18.57%
  • 3 Years:: 64.80%
  • 1 Year:: 95.72%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -252525252525252525252525
Equity Capital24.9925.0425.1425.1725.2425.2425.2425.2425.2425.2425.2725.27
Other Liabilities -2792933294675226416627567777858771,045
Trade Payables6569177233202265286401350376400490
Advance from Customers65651892200000
Other liability items207219146229302366354355427409477555
Total Liabilities1,3671,6221,9132,3302,7093,2173,8243,9053,9684,1084,4585,185
Fixed Assets -5636366989131,0751,3061,7531,9771,9461,8551,7401,841
Gross Block7648789861,2851,5251,8512,4662,1372,2772,3592,4132,689
Accumulated Depreciation201242288372450545713161331504673848
Other Assets -7318981,0721,2801,4821,7171,7221,7021,7161,9642,3292,611
Trade receivables343392370345416449354441502594632839
Cash Equivalents6889556911316218131260152
Loans n Advances85131196183187233219220263315331301
Other asset items-3-43579921281194660515151
Total Assets1,3671,6221,9132,3302,7093,2173,8243,9053,9684,1084,4585,185

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -155194215319387515455696271324496554
Profit from operations269337381521579763540313420468732960
Loans Advances000000-27290000
Operating borrowings412430000000000
Other WC items0000-379-12108-34-213992
Working capital changes-90-98-102-122-100-118-10412-95-87-129-259
Direct taxes-22-45-64-80-92-130-74-29-54-57-108-146
Other operating items-1-10000000000
Cash from Investing Activity --106-127-199-249-261-362-686-214-146-119-123-498
Fixed assets purchased-79-143-195-260-229-371-555-242-135-72-67-273
Fixed assets sold1111111221213
Investments purchased-482-482-618-1,316-1,806-1,903-2,0380-2,100-2,45600
Investments sold4554916101,3161,8321,9062,04642,1072,46300
Subsidy received0000000000150
Investment income000000050000
Interest received6659713209401542
Dividends received110110000000
Invest in subsidiaries-8-1-2-2-0-1-0-100-83-27
Investment in group cos0000-1-7-220-30-15-49
Shares acq cancelled00000000010135
Acquisition of companies0000-670000-5900
Other investing items00-120-0-1389-21-7-1-209
Cash from Financing Activity --51-64-17-69-81-138255-414-156-130-223-133
Proceeds from shares232100000050
Proceeds from debentures500050200000000
Redemption of debentures000-17-330-55-5-5-500
Proceeds from borrowings1571961371106748815268610107
Repayment of borrowings-48-69-42-157-97-111-110-517-196-182-195-115
Proceeds from deposits000000000000
Interest paid fin-29-29-29-37-34-28-31-28-23-22-17-14
Dividends paid-34-38-44-47-47-66-37-15-0-15-15-122
Other financing items-7-3000000033012
Net Cash Flow-22-1145142568-3174150-76

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %16%25%26%24%24%27%13%4%9%9%17%20%
Debtor Days999272545551425759686471
Inventory Turnover2.022.141.981.761.711.591.451.361.471.461.381.44

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Ipca Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.